Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
2 types of Adrenergic receptors |
Alpha and beta receptors |
|
Alpha 1 receptors G protein |
Gq |
|
Alpha 2 G protein |
Gi |
|
Beta 1&2 g protein |
Gs |
|
Alpha 1 receptor locations |
Eye Bladder Blood vessels |
|
Alpha 2 receptor locations |
Pancreas Prejunctional synapse |
|
Beta 1 receptor locations |
Heart |
|
Beta 2 receptor locations |
Lungs GI Pancreas |
|
Alpha 1 activation |
Mydraisis Vasoconstriction Urinary retention |
|
Alpha 2 activation |
Decrease insulin secretion Decrease I'm NT release |
|
Beta 1 receptor activation |
Increased HR |
|
Beta 2 receptor activation |
Bronchodilation Vasodilation Increase GI motility Increased insulin |
|
Albuterol receptor |
B2 |
|
Isoproterenol |
Receptors: B1&2 - catecholamines - less adverse side effects than epi n norepi |
|
Epinephrine receptor |
A1&2 B1&2 |
|
Drugs capable of A1 activation |
Epi Norepi Dopamine Phenylephrine |
|
A1 =? |
Vasoconstriction |
|
B1 =? |
Heart |
|
B2 =? |
Lungs |
|
Therapeutic effect B1 activation |
HF Shock Improve tissue perfusion AV block |
|
Adverse effect B1 |
Angina pectoris Dysrhythmia |
|
Therapeutic application B2 activation |
Asthma (Bronchodilation) Preterm labor (uterine relaxation) |
|
B2 activation adverse effecrs |
Hyperglycemia (in pts with diabetes) Tremors |
|
Epi side effects |
Hypertensive crisis |
|
Catecholamines |
Epi, norepi, dopamine |
|
Norepi Therapeutic uses |
Hypotension Cardiac arrest |
|
Difference btwn norepi n epi |
- doesn't activate B2 receptors |
|
Norepi n epi interactions |
MAOIs TCA Adrenergic blocking agents |
|
Isoproterenol |
Has few adverse effects than epi n norepi - same drug interactions |
|
Catecholamines v. Noncatecolamines |
|
|
Adrenergic antagonist |
Directly blocks adrenergic receptors - all have reversible effects - more selective than agonist |
|
2 types of adrenergic antagonists |
Alpha adrenergic blocker Beta adrenergic blocker |
|
Therapeutic effects of alpha blockade |
- Tx of primary HTN (Vasodilation: A1 receptor blockade) - antidote to overdose of alpha adrenergic agonist - BPH - Pheochromocytoma (secrete alot of catecholamines Increasing BP) - Raynauds
|
|
Adverse effects of A1 blockade |
Orthostatic HTN Reflex tachycardia Na+ retention |
|
Prazosin |
Competitive agonist - Tx of HTN |
|
Tamsulosin (flowmax) |
Tx of BPH Alpha 1 antagonist |
|
Beta adrenergic antagonist 1 Therapeutic application |
- HTN - cardiac dysrythymia - MI - HF - hyperthyroidism - stage fright - Glaucoma |
|
Metropolol |
Beta blocker - Chosen over non selective beta blockers bc of diabetes n asthma pts |
|
B2 activation and Hypokalemia in diabetics |
- B2 receptors increase breakdown of glycogen to glucose - In diabetic pts cnt maintain blood glucose balance |
|
MAOs |
One of the enzymes that inactivate epi and other catecholamines
** pt taking MAOIs shouldn't have epi (prolongs effects) |
|
Ephedrine |
Receptors: Alphas n betas Mixed acting drug Noncatecolamine Activation when binder to alpha n beta sites |